Targeted phytochemical active extraction, impurity-free separation, and preclinical bio-validation pathways compliant with USP, Ph. Eur., and cGMP benchmarks.
OEM In Vitro Test /Research Service Manufacturers, Suppliers
View Service Details
ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins. Manufacturer, Suppliers
View Service Details
OEM Animal study Supplier, Suppliers
View Service Details
China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers
View Service Details
ODM Clinic study (Phase1 - Phase 4） Manufacturer, Suppliers
View Service Details
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
View Service Details
Advanced Botanical Active High-Throughput Assay & Phytochemical Profiling
View Service Details
Phytochemical Harvest Precision & Seasonal Potency Chromatography Evaluation
View Service DetailsComprehensive mitigation strategies against polycyclic aromatic hydrocarbons (PAHs), ethylene oxide (EtO), elemental impurities, mycotoxins, and agrochemical residuals.
Utilizing high-selectivity supercritical CO2 fluid extraction (SFE) coupled with molecular distillation to strip away organochlorine, organophosphorus, and synthetic pyrethroids down to nondetectable quantification limits (LOQ < 0.01 mg/kg) compliant with European Pharmacopoeia (EP 2.8.13).
Employing macroporous adsorbent resins and functionalized chelating membranes specifically targeted to strip Arsenic (As), Cadmium (Cd), Lead (Pb), and Mercury (Hg) in strict compliance with USP <2232> limits for elemental contaminants in dietary botanical extracts.
Eliminating non-thermal gas sterilization risks through continuous high-pressure steam sterilization cycles, mitigating Ethylene Oxide and 2-Chloroethanol residues completely while securing Benzo(a)pyrene and PAH4 levels under strict European Regulation (EU) 2023/915 parameters.
Synthesizing geographic raw botanical diversity, full-scale industrial scalability, and modern pharmacopeial analytical methodologies.
Access to authenticated wild-crafted and GAP-cultivated botanical habitats across varied Chinese biomes. Direct sourcing controls active compound seasonality while preventing baseline environmental soil contamination from the source root.
Dual-standard development bridging the Chinese Pharmacopoeia (ChP) with global standards (USP, Ph. Eur., BP). Validated fingerprinting techniques (HPLC, HPTLC, GC-MS/MS, ICP-MS) provide unassailable batch-to-batch chemical reproducibility.
Closed-loop, automated extraction complexes running in continuous shifts ensure complete solvent recovery, zero cross-contamination risk, and cost-optimized unit economics for enterprise pharmaceutical and FMCG global supply contracts.
Operating exclusively under entrusted CDMO contract agreements. Proprietary solvent gradients, target fraction formulations, and purification parameters remain secured through legal confidentiality frameworks and segregated manufacturing rooms.
Enterprise pharmaceutical and nutraceutical buyers are actively phasing out unverified raw plant powders in favor of certified, contaminant-depleted target isolates.
Consumer scrutiny over artificial excipients, carcinogens, and pesticide traces in functional foods is forcing brands to demand zero-tolerance certifications from tier-one manufacturers, safeguarding brand enterprise value against recall risks.
Advancing active pharmaceutical botanical ingredients (APIs) into IND/NDA pipelines requires absolute purity profiles, robust preclinical toxicology datasets (LD50, Ames, Genotoxicity), and multi-batch validation that satisfy FDA Botanical Drug Guidance.
Replacing toxic petroleum-derived solvents (hexane, benzene) with bio-based ethanol, subcritical water extraction, and closed-circuit membrane fractionation to comply with ESG commitments without reducing botanical bioactivity yields.
From purified active fractions to shelf-ready dosage formats designed for target regulatory markets across Europe, North America, and Asia-Pacific.
Micro-encapsulated free-flowing powders, sustained-release hard-gel capsules, and water-dispersible granules designed to maintain bio-absorption efficiency while preventing active compound oxidation or cross-interaction with matrix stabilizers.
High-clarity, decolorized, and odorless botanical fractions formulated for clinical dermocosmetics. Depleted of heavy pigments and allergens while preserving targeted polyphenolic, flavonoid, or triterpenoid skin-protective pathways.
Sterile liquid concentrates, single-herb standardized aqueous decoctions, and hospital-registered oral liquids developed with full stability profiling and chromatographic consistency across dynamic clinical hospital applications.
Specific insights into quality verification, testing methodologies, batch qualification, and international contract manufacturing procedures.
Accelerate your product launch timeline with validated extraction methodologies, safety screening, and commercial dosage form manufacturing.
OEM In Vitro Test /Research Service Manufacturers, Suppliers
View Service Details
ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins. Manufacturer, Suppliers
View Service Details
OEM Animal study Supplier, Suppliers
View Service Details
China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers
View Service Details
ODM Clinic study (Phase1 - Phase 4） Manufacturer, Suppliers
View Service Details
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
View Service Details
Precision Pilot-to-Commercial Phytochemical Scale-Up & Fraction Isolation
View Service Details
Finished Dosage Manufacturing, Micro-Encapsulation & Formulation CDMO
View Service Details